Asia Pacific Starch Softgel Capsules Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider); and Country


No. of Pages: 101    |    Report Code: TIPRE00012984    |    Category: Life Sciences

Asia Pacific Starch Softgel Capsules Market
Buy Now

Market Introduction

The starch softgel capsules are usually derived from natural sources and used as nutritional supplements by patients suffering with various medical conditions. These Softgel capsules are usually free of genetic modifications and are manufactured adhering to strict quality standards. The Softgel capsules are available in gelatin as well as non-gelatin composition for people with vegetarian and non-vegetarian preferences. The Softgels are one of the most common and widely used oral dosage form of pharmaceuticals as well as nutraceuticals.


Get more information on this report

Asia Pacific Starch Softgel Capsules Strategic Insights

Strategic insights for the Asia Pacific Starch Softgel Capsules provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-starch-softgel-capsules-market-strategic-framework.webp
Get more information on this report

Asia Pacific Starch Softgel Capsules Report Scope

Report Attribute Details
Market size in 2019 US$ 82.55 Million
Market Size by 2027 US$ 122.54 Million
Global CAGR (2020 - 2027) 5.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Application
  • Pharmaceutical
  • Health Supplements
By Distribution Channel
  • Supermarket and Hypermarket
  • Pharmacy and Drugstore
  • Online Provider
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Hunan Er-Kang Pharmaceutical Co. Ltd
  • Softcaps
  • Fuji Capsule Co. Ltd.
  • Aenova Holding GmbH
  • Sirio Pharma Co. Ltd.
  • Get more information on this report

    Asia Pacific Starch Softgel Capsules Regional Insights

    The geographic scope of the Asia Pacific Starch Softgel Capsules refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-starch-softgel-capsules-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The Asia Pacific starch softgel capsule market is expected to reach US$ 122.54 million in 2027 from US$ 82.55 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027. Factors such advantages of softgel capsules and rise in preference for vegetarian capsules Asian countries is expected to boost the market growth over the years. Moreover, developing healthcare industry in Asia Pacific region is likely to create growth opportunities for the market to grow.

    Key Market Segments

    By application, the health supplements segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of the distribution channel, supermarket and hypermarket, pharmacy and drugstore, and online provider. The pharmacy and drugstore segment held the highest share of the starch softgel capsules market in 2019, by distribution channel. However, the online provider segment is anticipated to witness growth at a significant rate during the forecast period, 2020 to 2027.

    Major Sources and Companies Listed

    Some of the major secondary sources for Asia Pacific Starch Softgel Capsules Market included in the report are Center for Disease Control and Prevention, World Heart Foundation, Global Nutrition Report, India Brand Equity Foundation, The Korean Diabetes Association, China Government Portal Site: China.org.cn among others.

    Reasons to buy the report

    • To understand the Asia Pacific starch softgel capsules market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific starch softgel capsules market
    • Efficiently plan M&A and partnership deals in Asia Pacific starch softgel capsules market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific starch softgel capsules market
    • Obtain market revenue forecast for market by various segments from 2019-2027 in Asia Pacific.

     

    Asia Pacific Starch Softgel Capsules Market –

    By Application

    • Pharmaceutical
    • Health Supplements
    • Others

     

    By Distribution Channel

    • Supermarket and Hypermarket
    • Pharmacy and Drugstore
    • Online Provider

    By Country

    • China
    • India
    • Japan
    • South Korea
    • Australia

     

    Company Profiles

    • Hunan Er-Kang Pharmaceutical Co. Ltd
    • Softcaps
    • Fuji Capsule Co. Ltd.
    • Aenova Holding GmbH
    • Sirio Pharma Co. Ltd.

     

     

     

    The List of Companies - Asia Pacific Starch Softgel Capsules Market

    1. Hunan Er-Kang Pharmaceutical Co. Ltd
    2. Softcaps
    3. Fuji Capsule Co. Ltd.
    4. Aenova Holding GmbH
    5. Sirio Pharma Co. Ltd.
    Frequently Asked Questions
    How big is the Asia Pacific Starch Softgel Capsules Market?

    The Asia Pacific Starch Softgel Capsules Market is valued at US$ 82.55 Million in 2019, it is projected to reach US$ 122.54 Million by 2027.

    What is the CAGR for Asia Pacific Starch Softgel Capsules Market by (2020 - 2027)?

    As per our report Asia Pacific Starch Softgel Capsules Market, the market size is valued at US$ 82.55 Million in 2019, projecting it to reach US$ 122.54 Million by 2027. This translates to a CAGR of approximately 5.2% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Starch Softgel Capsules Market report typically cover these key segments-

    • Application (Pharmaceutical, Health Supplements)
    • Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider)

    What is the historic period, base year, and forecast period taken for Asia Pacific Starch Softgel Capsules Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Starch Softgel Capsules Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Starch Softgel Capsules Market?

    The Asia Pacific Starch Softgel Capsules Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Hunan Er-Kang Pharmaceutical Co. Ltd
  • Softcaps
  • Fuji Capsule Co. Ltd.
  • Aenova Holding GmbH
  • Sirio Pharma Co. Ltd.
  • Who should buy this report?

    The Asia Pacific Starch Softgel Capsules Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Starch Softgel Capsules Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now